No Data
No Data
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?
Institutional Investors Control 53% of Novavax, Inc. (NASDAQ:NVAX) and Were Rewarded Last Week After Stock Increased 6.3%
Novavax Analyst Ratings
H.C. Wainwright Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $19
Jim Cramer Is 'Not A Fan' Of Novavax, Says This Tech Stock Is 'Expensive'
Krystian 1983 : This is on the Way to explode 200